Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Controlling levodopa and deep brain stimulation induced dystonia with interleaving and fractionalized current steering
Non-Pharmacological Interventions · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Correlating subcortical structure and function in idiopathic Parkinson’s disease: A cross-sectional morphometric and [18F]-DOPA PET study
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Correlation between substantia nigra measurement and UPDRS
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Correlation of local field potentials (LFPs) to electromyography (EMG) of the rostral zona incerta (rZI) and subthalamic nucleus (STN) in Parkinson’s Disease (PD)
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease
Non-Motor Symptoms · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 67
- Next Page»